Inhalation Article: April 2024
Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery In this article, Dr Clair Brooks, Applications Special…
View ArticleOINDPnews Article: February 2024
In this article with OINDPnews, our Application Specialist, Dr Clair Brooks, discusses the recent EMA guidance on data requirement…
View ArticlePoster: DDL 2023
Matching DUSA and Impactor Rise-Time Profiles with a Volume and Resistance Compensator Ensuring mass-balance in inhaler device tes…
View ArticleONdrugDelivery Article: November 2023
Perfect Timing for the Automation of OINDP Testing In this article, Adam Smith, Product Manager – Automation, and Clair Broo…
View ArticlePoster: RDD 2023 (Henriques et al.)
Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition using the Alberta …
View ArticlePMPS Q&A (Samedan): April 2023
Nasal Drug Product Development Matthew Fenn, Head of Business Development, sat down with PMPS Magazine to discuss the topic of nas…
View ArticlePoster: DDL 2022 (VRC)
Matching Impactor Rise-Time Profiles with a Volume and Resistance Compensator Abbreviated Impactor Measurement (AIM) has several p…
View ArticlePoster: DDL 2022
Developing Methods for Automated Delivered Dose Uniformity (DDU) Testing for Nasal Sprays The COVID-19 pandemic has further stimul…
View ArticlePoster: RDD 2022
Investigating the Impact of Electrostatics on Delivered Dose Uniformity for pMDIs In this poster published at RDD 2022, an automat…
View ArticlePoster: DDL 2022 (Mitchell et. al)
Flow Rate-Rise Time Profiles from Model Dry Powder Inhaler (DPI) Testing of Abbreviated Impactor Systems Compared with Their Full …
View ArticleQ&A: OINDPnews 2022
Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers …
View Article